3-Aminopiperidine-2,6-Dione Hydrochloride CAS 24666-56-6;2686-86-4 Kuchena >99.0% Lenalidomide Intermediate Factory
Ruifu Chemical ndiyo inotungamirira kugadzira 3-Aminopiperidine-2,6-Dione Hydrochloride (CAS: 24666-56-6; 2686-86-4) nepamusoro, pakati pePomalidomide (CAS: 19171-19-8).Ruifu Chemical inogona kupa kutumirwa kwepasirese, mutengo wemakwikwi, sevhisi yakanakisa, idiki uye yakawanda huwandu huripo.Tenga 3-Aminopiperidine-2,6-Dione Hydrochloride, Please contact: alvin@ruifuchem.com
| Chemical Name | 3-Aminopiperidine-2,6-Dione Hydrochloride |
| Mashoko anoreva zvakafanana | 3-Aminopiperidine-2,6-Dione HCl;3-Amino-2,6-Piperidinedione Hydrochloride;2,6-Dioxopiperidine-3-Ammonium Chloride |
| Nhamba yeCAS | 24666-56-6 |
| Inoenderana CAS | 2686-86-4;25181-50-4 |
| Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
| Molecular Formula | C5H9ClN2O2 |
| Molecular Weight | 164.59 |
| Melting Point | 120 ℃ |
| COA & MSDS | Available |
| Origin | Shanghai, China |
| Brand | Ruifu Chemical |
| Item | Zvinotsanangurwa |
| Chitarisiko | Off-White Crystalline Powder |
| Kuchena / Analysis Method | >99.0% (HPLC) |
| Kunyorova (KF) | <0.50% |
| Kurasika paKuomesa | <0.50% |
| Residue paIgnition | <0.20% |
| Zvose Zvisina Kuchena | <1.00% |
| Infrared Spectrum | Inopindirana neChimiro |
| Test Standard | Enterprise Standard |
| Usage | Pakati peLenalidomide (CAS: 191732-72-6) |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
3-Aminopiperidine-2,6-Dione Hydrochloride (CAS: 24666-56-6; 2686-86-4) iri pakati pekugadzirira Lenalidomide (CAS: 191732-72-6).Lenalidomide imhando yemishonga inorwisa tumor yakagadziriswa neAmerican biological pharmaceutical makambani.Iine mabasa akawanda akadai se anti-tumor, immune regulation uye anti-angiogenesis.Inogona kuvharidzira kugadzirwa kwe cytokines inoputika, uye kuwedzera kuvharidzirwa kweperipheral blood mononuclear anti-inflammatory cytokines.Inogona kutadzisa kukura kwevarwere 'akawanda myeloma masero uye MM1S cell.Zvidzidzo zvekiriniki zviviri zvakasiyana-siyana zvisingaverengeki zvakapetwa kaviri-bofu-placebo-inodzorwa nekiriniki inoongorora kuchengetedzwa uye kurapa mhedzisiro ye lenalidomide inoshandiswa kune akawanda myeloma.Zvichangoburwa ongororo yekiriniki mhedzisiro inoratidza kuti lenalidomide haina kungoita kurapa kwekurapa MDS neMM, asiwo pakurapa myeloma, leukemia, metastatic renal cell carcinoma, yakasimba bundu, idiopathic generalized amyloidosis uye systemic bone marrow fibrosis chirwere chine mwongo usina kuibva.Muna Zvita 2005, US Food and Drug Administration (FDA) yakabvumidza lenalidomide kuti ishandiswe mukurapa myelodysplastic syndrome (MDS).
